1. ScholarBank@NUS

Seng Gee Lim

rp00481

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Seng Gee Lim
Variants
Lee Lim, S.G.
Lim, S.G.
Seng, Foreword Gee Lim
Seng, G.L.
Lim Seng Gee
Lim, Seng Gee
Lim, S.-G.
 
Main Affiliation
 
Faculty
 
Email
mdclimsg@nus.edu.sg
 

Publications

Refined By:
Date Issued:  [2000 TO 2009]
Date Issued:  2006
Type:  Article

Results 1-17 of 17 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
12006A double-blind placebo-controlled study of emtricitabine in chronic hepatitis BLim, S.G. ; Ng, T.M.; Guan, R.; Kung, N.; Krastev, Z.; Volfova, M.; Husa, P.; Lee, S.S.; Chan, S.; Shiffman, M.L.; Washington, M.K.; Rigney, A.; Anderson, J.; Mondou, E.; Snow, A.; Sorbel, J.; Rousseau, F.
22006A randomized, placebo-controlled trial of thymosin-α1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis BLim, S.G. ; Wai, C.-T. ; Lee, Y.M. ; Dan, Y.Y.; Sutedja, D.S.; Wee, A. ; Suresh, S.; Wu, Y.J.; Machin, D.; Lim, C.C.; Fock, K.M.; Koay, E. ; Bowden, S.; Locarnini, S.; Ishaque, S.M.
32006Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load?Cheng, Y. ; Seet, B.L.; Ong, C.S.L.; Wasser, S. ; Lim, S.G. ; Tan, T.M.C. ; Peter, F.J. 
42006Impact of new legislation on presumed consent on organ donation on liver transplant in Singapore: A preliminary analysisLow, H.-C.; Lim, S.-G. ; Wai, C.-T. ; Costa, M.D.; Prabhakaran, K. ; Kaur, M.; Wee, A. 
52006Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinomaLee, S.-C.; Soo, R.; Guo, J.-Y.; Goh, B.-C. ; Lim, S.-G. ; Putti, T. ; Soong, R. ; Hsieh, W.-S.; Tao, Q.
6Jul-2006Long-term post-liver transplant complications of renal impairment and diabetes mellitus: Data from SingaporeSutedja, D.S.; Wai, C.T. ; Teoh, K.F.; Lee, Y.M. ; Diddapur, R.K.; Isaac, J. ; Mak, K.; Da Costa, M.; Lee, K.H. ; Prabhakaran, K. ; Tan, K.C.; Lim, S.G. 
72006Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 YearsHadziyannis, S.J.; Tassopoulos, N.C.; Heathcote, E.J.; Chang, T.; Kitis, G.; Rizzetto, M.; Marcellin, P.; Lim, S.G. ; Goodman, Z.; Ma, J.; Brosgart, C.L.; Borroto-Esoda, K.; Arterburn, S.; Chuck, S.L.
8Jul-2006MELD may not be the better system for organ allocation in liver transplantation patients in SingaporeLee, Y.M. ; Fernandez, M.; Da Costa, M.; Lee, K.H. ; Sutedja, D.S.; Tai, B.C. ; Tan, K.C.; Isaac, J. ; Prabhakaran, K. ; Lim, S.-G. 
927-Jun-2006Non-invasive models for predicting histology in patients with chronic hepatitis BWai, C.-T. ; Oo, A.M. ; Lim, S.G. ; Dan, Y.-Y.; Chua, W.; Mak, B.; Cheng, C.L.; Wee, A. ; Chan, E.
10Mar-2006Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: Pharmacodynamic implicationsZhou, X.-J.; Lim, S.-G. ; Lloyd, D.M.; Chao, G.C.; Brown, N.A.; Lai, C.-L.
112006Population pharmacokinetics of tacrolimus in whole blood and plasma in Asian liver transplant patientsWai, J.S. ; Lai, S.T.; Holmes, M.J. ; Aw, M.; Seng, H.Q. ; Kang, H.L. ; Seng, G.L. ; Prabhakaran, K.; Sui, Y.C. ; Ho, P.C. 
12May-2006Prophylactic strategies for Hepatitis B patients undergoing liver transplant: A cost-effectiveness analysisDan, Y.Y.; Wai, C.T. ; Yeoh, K.G. ; Lim, S.G. 
132006Prophylactic strategies for Hepatitis B patients undergoing liver transplant: A cost-effectiveness analysisDan, Y.Y.; Wai, C.T. ; Yeoh, K.G. ; Lim, S.G. 
142006Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis BLim, S.G. ; Krastev, Z.; Ng, T.M.; Mechkov, G.; Kotzev, I.A.; Chan, S.; Mondou, E.; Snow, A.; Sorbel, J.; Rousseau, F.
152006Referral patterns and waiting times for liver transplantation in SingaporeLim, S.G. ; Wai, C.T. ; Sutedja, D.S.; Lee, Y.M. ; Da, Costa M.; Lee, K.H. ; Aw, M.M. ; Quak, S.H. ; Prabhakaran, K. ; Isaac, J. ; Tan, C.K.
162006Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agentsChen, Y.; Kong, K.H. ; Ang, T.H.; Lam, Y. ; Tan, T.M.C. ; Bai, J.; Li, Y. ; Lim, S.G. 
172006Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agentsChen, Y. ; Kong, K.H.; Ang, T.H.; Lam, Y. ; Tan, T.M.C. ; Bai, J. ; Li, Y.; Lim, S.G.